5 May 2011 15:37

For immediate release | 5 May 2011 |
Â
Â
Futura Medical plc
("Futura" or "the Company")
Â
Result of AGM
Â
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, confirms that all resolutions were duly passed at its Annual General Meeting held earlier today.
Â
For any further information please contact:
Â
Futura Medical plc | Â |
James Barder, Chief Executive  | Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
 |  |
 Nomura Code Securities Limited |  |
Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
  |  |
For media enquiries please contact: | Â |
 |  |
Buchanan Communications | Â |
Mark Court / Jessica Fontaine | Tel: +44 (0)20 7466 5000 |
Â
Â
Notes to Editors
Â
Futura Medical plc
Â
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Â
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com